Item 5. Market for Registrant’s Common Equity
ITEM
5. MARKET FOR REGISTRANT’S COMMON EQUITY; RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market
for Registrant’s Common Equity
The
Company became subject to Securities Exchange Act Reporting Requirements in October 2012. The symbol “BIOF” is assigned for
its securities. The Company’s common stock commenced trading on the OTCBB on February 5, 2014, under the symbol ALLM and changed
to BIOF on August 27, 2021.
On
November 13, 2018, the Company filed a Form 15, suspending its duty to file reports under sections 13 and 15(d) of the Securities Exchange
Act. The Company has subsequently traded on the Pink Sheets. On January 5, 2021, the Company filed a Form 10 Registration Statement to
become fully reporting again and has been fully reporting ever since.
Options
and Warrants
At
various times over the years, warrants have been issued for services, as parts of contracts, or in settlement agreements. Warrants also
have been issued as a part of some financings.
As
of the date of filing, not including expired or exercised warrants, the Company has issued warrants to purchase an aggregate of 18,098,310
shares of common stock. The exercise prices associated with these agreements range from $0.05 to $0.30 and terms range from twenty four
months to ten (10) years.
As
of the date of this filing, the company has issued option agreements to its independent directors, officers, employees, and consultants,
to purchase an aggregate of 65,530,000 shares of common stock of which 26,805,000 have vested and 38,725,000 have not yet vested. The
exercise prices range from $0.05 to $0.30 and terms range from five (5) to ten (10) years.
Other
than the foregoing, none of the Company’s shares of Common Stock are subject to outstanding options or warrants.
6
Holders
As
of the date of filing, there were 299,416,769 shares of common stock outstanding and approximately 342 stockholders of record.
Transfer
Agent and Registrar
The
Company’s transfer agent is ClearTrust, LLC., 16540 Pointe Village Dr., Suite 205, Lutz, FL 33558, Phone: 813-235-4490.
Dividend
Policy
The
Company has never paid any cash dividends on its Common Stock and does not anticipate paying any cash dividends on its Common Stock in
the foreseeable future. The Company intends to retain future earnings to fund ongoing operations and future capital requirements of its
business. Any future determination to pay cash dividends will be at the discretion of the Board of Directors and will be dependent upon
the Company’s financial condition, results of operations, capital requirements and such other factors as the Board of Directors
deems relevant.
Securities
Authorized for Issuance Under Equity Compensation Plans
There
are currently, as of the date of filing, fully earned and vested option agreements in place to purchase an aggregate of 26,805,000 shares
of common stock under the Company’s 2021 Employee, Director Stock Plan and there are additional agreements vesting over the next
5 years, or conditional upon events, to purchase an additional 38,725,000 shares of common stock.
Plan Category
Maximum number of securities reserved under equity compensation plan (1)
Weighted average exercise price of outstanding options, warrants, and rights
Number of securities to be issued upon exercise of outstanding options, warrant, and rights
Equity compensation plans approved by security holders
55,439,038
$ 0.13
51,080,000
Equity compensation plans not approved by security holders
0
n/a
n/a
Total
55,439,038
51,080,000
(1) As
of December 31, 2022.
The
Plan provides that awards may be granted to officers, employees, consultants, or directors of the Company and its affiliates (“ Eligible
Persons ”). The Plan permits the board of directors of the Company to grant three types of awards (“ Awards ”)
to Eligible Persons: (a) a stock appreciation right (“ Stock Appreciation Right ”); (b) a stock option (“ Stock
Option ”); and (c) a stock award (“ Stock Award ”).
Stock
Options may be granted alone or in addition to other Awards granted under the Plan and may be of two types: (a) incentive Stock Options;
and (b) non-qualified Stock Options. The exercise price per share under a Stock Option is determined by the administrator of the Plan
(which is either the entire board or a designated committee comprised solely of independent directors); provided, however, that such
exercise price is not less than the fair market value per Purchaser Share on the date the Stock Option is granted, subject to certain
exceptions. The term of each Stock Option is fixed by the administrator of the Plan and no incentive Stock Option may be exercisable
more than 10 years after the date such incentive Stock Option is granted. The Plan provides that other terms and conditions may be attached
to a particular Stock Option, such terms and conditions to be referred to in an option agreement.
7
In
the event an option holder ceases to be an Eligible Person other than by reason of death, disability or cause, the option holder may
exercise any Stock Option granted to him or her to the extent that such Stock Option is exercisable on the date of such termination.
In the event an option holder ceases to be an Eligible Person by reason of death or disability, the option holder or his or her representative,
as applicable, may exercise any Stock Option granted to him or her to the extent that such Stock Option is exercisable on the date of
such death or disability. All outstanding and unexercised Stock Options of an option holder will be cancelled in the event that such
person ceases to be an Eligible Person by reason of cause.
Stock
Appreciation Rights may be granted either on a stand-alone basis or in conjunction with all or part of any Stock Option granted under
the Plan. Stock Appreciation Rights granted on a stand-alone basis may be exercisable only at such time or times and to such extent as
determined by the administrator of the Plan. Stock Appreciation Rights granted in conjunction with all or part of any Stock Option may
be exercisable only at the time or times and to the extent that the Stock Options to which they relate are exercisable. Upon the exercise
of a Stock Appreciation Right, a holder will be entitled to receive an amount in cash, Purchaser Shares or both, which in the aggregate
is equal in value to the difference in the fair market value of the Purchaser Shares at the date of exercise less the fair market value
of the Purchaser Shares at the date of grant.
Stock
Awards may be directly issued under the Plan, subject to such terms, conditions, performance requirements, restrictions, forfeiture provisions,
contingencies and limitations as the administrator of the Plan may determine.
Subject
to adjustment as provided in the Plan, the aggregate number of shares of common stock which may be delivered under the Plan shall not
exceed a number equal to 15% of the total number of shares of common stock outstanding. The maximum number of shares of common stock
which may be delivered under the Plan shall automatically increase by a number sufficient to cause the number of shares of common stock
covered by the Plan to equal 15% of the total number of shares of common stock then outstanding, assuming for this purpose the conversion
into common stock of all outstanding securities that are convertible by their terms (directly or indirectly) into common stock. The exercise
price per share of common stock purchasable under a Stock Option shall be determined by the administrator of the Plan; provided, however,
that the exercise price per share shall be not less than the Fair Market Value (as defined in the Plan) per share on the date the Stock
Option is granted, or if the Stock Option is intended to qualify as an Incentive Stock Option and is granted to an individual who is
a Ten Percent Holder (as defined in the Plan), not less than 110% of such Fair Market Value per share. The term of each Stock Option
shall be fixed by the administrator of the Plan, but no Incentive Stock Option shall be exercisable more than 10 years (or five years
in the case of an individual who is a Ten Percent Holder) after the date the Incentive Stock Option is granted.
8
Recent
Sales of Unregistered Securities
Below
is a list of securities sold by the Company from January 1, 2022 through the date of filing which were not registered under the Securities
Act.
Entity
Date of Investment
Title of Security
Amount of Securities Sold
Consideration
Tom Camerlengo
01/12/22
Common Stock
150,000
Exercise of Warrants
North Equities
03/05/22
Common Stock
322,581
Professional Services
Bill Fitzpatrick
03/10/22
Common Stock
100,000
Professional Services
NWBB, Inc
03/10/22
Common Stock
25,200
Professional Services
NWBB, Inc
04/22/22
Common Stock
28,600
Professional Services
Ben Slager
04/29/22
Common Stock
500,000
Purchase @ $0.15 per share
AES Capital Resource Fund
05/02/22
Common Stock
500,000
Purchase @ $0.15 per share
Chris and Angela Kneppers
05/02/22
Common Stock
2,333,333
Purchase @ $0.15 per share
Raymond Leon
05/04/22
Common Stock
500,000
Purchase @ $0.15 per share
Melvin H. Eaton II
05/23/22
Common Stock
333,333
Purchase @ $0.15 per share
Mark Monahan
05/23/22
Common Stock
333,333
Purchase @ $0.15 per share
Johan Foster
05/26/22
Common Stock
25,000
Professional Services
Caroline Libra
05/26/22
Common Stock
25,000
Professional Services
Thomas Camerlengo
05/31/22
Common Stock
200,000
Exercise of Options
Steve Paul
07/07/22
Common Stock
166,667
Purchase @ $0.15 per share
Randall Brodsky
07/11/22
Common Stock
333,333
Purchase @ $0.15 per share
NWBB, Inc.
07/12/22
Common Stock
34,000
Professional Services
Mudai Nakagawa
07/22/22
Common Stock
500,000
Purchase @ $0.15 per share
NWBB, Inc.
08/17/22
Common Stock
29,444
Professional Services
Linda Gulla
08/22/22
Common Stock
23,889
Professional Services
NWBB, Inc.
08/29/22
Common Stock
26,111
Professional Services
Bohdan Rudawski
09/02/22
Common Stock
133,333
Purchase @ $0.15 per share
Mark Cox
09/02/22
Common Stock
333,333
Purchase @ $0.15 per share
Kathleen Doherty
09/12/22
Common Stock
133,333
Purchase @ $0.15 per share
NWBB, Inc.
09/20/22
Common Stock
55,398
Professional Services
Charles McCann
10/21/22
Common Stock
666,666
Purchase @ $0.15 per share
NWBB, Inc
10/21/22
Common Stock
12,805
Professional Services
Alvian Istrate
10/21/22
Common Stock
200,000
Purchase @ $0.15 per share
Alan Catterall
10/31/22
Common Stock
170,000
Purchase @ $0.15 per share
Wingard, LLC
10/31/22
Common Stock
70,000
Professional Services
Randall Brodsky
11/07/22
Common Stock
400,000
Purchase @ $0.15 per share
NWBB, Inc.
11/10/22
Common Stock
34,091
Professional Services
Richard Snider
12/14/22
Common Stock
100,000
Purchase @ $0.15 per share
Steven Dunkle Rev Trust
12/21/22
Common Stock
7,000,000
Exercise of Warrants
Mudai Nakagawa
12/22/22
Common Stock
150,000
Purchase @ $0.15 per share
Raymond Leon
01/03/23
Common Stock
200,000
Purchase @ $0.15 per share
James Cherwin
01/30/23
Common Stock
100,000
Purchase @ $0.15 per share
Edmund Burke
01/30/23
Common Stock
4,450,148
Exercise of Warrants
Edmund Burke
01/31/23
Common Stock
1,000,000
Exercise of Warrants
NWBB, Inc.
02/06/23
Common Stock
40,000
Professional Services
Ron Smith
02/06/23
Common Stock
166,666
Purchase @ $0.15 per share
Mark Monahan
02/17/23
Common Stock
333,333
Purchase @ $0.15 per share
Michael Fidler
02/17/23
Common Stock
200,000
Purchase @ $0.15 per share
Joseph Corry
02/17/23
Common Stock
100,000
Purchase @ $0.15 per share
William Newman
02/21/23
Common Stock
100,000
Purchase @ $0.15 per share
Johnny Anastasiades
03/01/23
Common Stock
135,000
Purchase @ $0.15 per share
Jozef Kneppers
03/06/23
Common Stock
1,333,333
Purchase @ $0.15 per share
James & Michelle Dupre
03/06/23
Common Stock
150,000
Purchase @ $0.15 per share
Randall Brodsky
03/07/23
Common Stock
400,000
Purchase @ $0.15 per share
Tamara Chapman Revocable Trust
03/08/23
Common Stock
333,333
Purchase @ $0.15 per share
John Comrie
03/08/23
Common Stock
333,333
Purchase @ $0.15 per share
William Fitzpatrick
03/24/23
Common Stock
100,000
Professional Services
The
securities issued in the above-mentioned transactions were issued in connection with private placements exempt from the registration
requirements of Section 5 of the Securities Act of 1933, as amended, pursuant to the terms of Section 4(a)(2) of that Act and Rules 504
and 506 of Regulation D.
9
ITEM
6. [Removed and reserved]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.